EP 249: Building the world's most detailed genetic map of inflammatory bowel disease with Carl Anderson

Value of the Information & Strength of the Argument

The value of the information is high, as it provides an in-depth look at the cutting-edge research on IBD genetics, including the construction of a unique single-cell atlas and its implications for understanding disease mechanisms and drug development. The argumentation is solid, grounded in the speaker’s extensive experience and specific examples from his research. He explains complex concepts clearly and supports his claims with references to ongoing studies and published work. The discussion is balanced, acknowledging uncertainties and the need for further research, particularly in areas like disease subtyping and the impact of treatment era effects.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, with the speaker being a leading expert in the field and the content based on peer-reviewed research and ongoing projects. The quality of sources is excellent, as the discussion references the IBDVerse study published in Nature (link provided in the description). The title accurately reflects the content, which focuses on building a detailed genetic map for IBD. The episode is well-structured, with clear chapters and a coherent flow of topics.

The title accurately reflects the content, which focuses on the construction and findings of the IBDVerse atlas, a detailed genetic map for inflammatory bowel disease.

9/10

The content is presented by a leading researcher in the field, with detailed references to ongoing research and published work. The discussion is grounded in scientific methodology and includes specific examples of genetic findings and their implications. The information is consistent with current understanding in the field, and the speaker demonstrates deep expertise.

• 00:00Intro to The Genetics Podcast
• 00:58Welcome to Carl
• 02:05The origins of IBDVerse and mapping genetic effects on gene regulation across gut cell types in IBD
• 05:43How anti-TNFs and newer genetically-supported IBD drugs have reshaped treatment
• 08:04Genetic versus environmental contributions to IBD
• 09:53Using single-cell data to uncover IBD disease subtypes
• 13:22Drug sequencing and immunogenicity in treatment response
• 16:52The backstory of building the IBDVerse atlas at scale
• 20:29How coding and non-coding IBD variants converge on the same genes and pathways
• 23:38The case for pathway-specific polygenic risk scores
• 28:17Building a longitudinal multi-omics dataset to predict IBD progression and drug response
• 30:08Why Sanger's next cohort targets sick and underrepresented patients rather than healthy volunteers
• 34:07What Carl looks for when interviewing PhD students and faculty candidates
• 39:20A call to junior scientists and closing remarks

• IBDverse study — Discussed as the main resource built by Carl Anderson's team, mapping genetic effects on gene regulation across gut cell types in IBD.

• IBDverse study — The primary source discussed in the episode, providing the scientific basis for the claims made.